glp-1 receptor agonist type 1 diabetes randomized trial Frontiers GLP-1 receptor agonists and diabetic
Description
Report suspected side effects through the MHRA Yellow Card scheme to contribute to medication safety monitoring
Common injection sites include the abdomen, upper arms, and front of the thighs
Semaglutide: a novel oral glucagonlike peptide receptor agonist for the treatment of type 2 diabetes mellitus
[PubMed Central ID: PMC4316233]
Kim et al
